Cargando…

Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: A systematic review and network meta-analysis

PURPOSE: This systematic review with network meta-analysis compared the efficacy and safety of currently licensed second-line treatments in patients with late stage non-small cell lung cancer (NSCLC). METHODS: Randomised controlled trials (RCTs) of participants with advanced/metastatic NSCLC receivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armoiry, Xavier, Tsertsvadze, Alexander, Connock, Martin, Royle, Pamela, Melendez-Torres, G. J., Souquet, Pierre-Jean, Clarke, Aileen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059384/ https://www.ncbi.nlm.nih.gov/pubmed/30044785 http://dx.doi.org/10.1371/journal.pone.0199575

Ejemplares similares

Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials
por: Connock, Martin, et al.
Publicado: (2019)

Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma
por: Armoiry, Xavier, et al.
Publicado: (2019)

Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation
por: Armoiry, Xavier, et al.
Publicado: (2020)

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review
por: Taylor-Phillips, Sian, et al.
Publicado: (2016)

Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair
por: Connock, Martin, et al.
Publicado: (2023)

Total Hip Replacement for the Treatment of End Stage Arthritis of the Hip: A Systematic Review and Meta-Analysis
por: Tsertsvadze, Alexander, et al.
Publicado: (2014)

Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages
por: Melendez-Torres, G. J., et al.
Publicado: (2018)

Potential impact on cost-effectiveness estimates of using immature survival data: a case study based on transcatheter edge-to-edge repair (TEER) used for patients with severe mitral regurgitation at high surgical risk
por: Connock, Martin, et al.
Publicado: (2023)

Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy
por: Nishimura, Tadashi, et al.
Publicado: (2022)

Test accuracy of drug and antibody assays for predicting response to antitumour necrosis factor treatment in Crohn’s disease: a systematic review and meta-analysis
por: Freeman, Karoline, et al.
Publicado: (2017)

Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
por: Reiter, Andreas, et al.
Publicado: (2022)

Safety and efficacy of nivolumab plus recombinant human endostatin in previously treated advanced non-small-cell lung cancer
por: Lv, Weize, et al.
Publicado: (2022)

Efficacy, Safety, and Pharmacokinetics of Beroctocog Alfa in Patients Previously Treated for Hemophilia A
por: Hyun, Shin Young, et al.
Publicado: (2015)

Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean
por: Velázquez, Raúl F., et al.
Publicado: (2017)

A comparison of licensed and un-licensed artisanal and small-scale gold miners (ASGM) in terms of socio-demographics, work profiles, and injury rates
por: Calys-Tagoe, Benedict N. L., et al.
Publicado: (2017)

The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma
por: Guan, Yelan, et al.
Publicado: (2023)

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
por: Zhu, Yilin, et al.
Publicado: (2019)

Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT
por: Kvistad, Silje Agnethe Stokke, et al.
Publicado: (2022)

Community-onset sepsis and its public health burden: protocol of a systematic review
por: Tsertsvadze, Alexander, et al.
Publicado: (2015)

The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials
por: Huang, Jiaxing, et al.
Publicado: (2016)

Psychosocial services provided by licensed cardiac rehabilitation programs
por: Bush, Montika, et al.
Publicado: (2023)

Short- and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome: a systematic review of randomised controlled trials and network meta-analysis
por: Armoiry, X., et al.
Publicado: (2018)

Efficacy and Safety of Low-Dose Nab-Paclitaxel Plus Tislelizumab in Elderly Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
por: Zhu, Wenyu, et al.
Publicado: (2022)

Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients
por: Baas, J. M., et al.
Publicado: (2015)

Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)
por: Yang, Yunpeng, et al.
Publicado: (2021)

Safety and efficacy of endoscopic retrograde cholangiopancreatography in previously treated liver cancer patients: a survival analysis
por: Li, Hong-Yu, et al.
Publicado: (2023)

Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis
por: Imai, Hisao, et al.
Publicado: (2020)

Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration
por: Gao, Guanghui, et al.
Publicado: (2022)

Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis
por: Auguste, Peter, et al.
Publicado: (2017)

Post-licensing safety of fosamprenavir in HIV-infected children in Europe†
por: Judd, Ali, et al.
Publicado: (2014)

License to glue
por: Wells, William A.
Publicado: (2004)

Franchising & Licensing
por: SHERMAN, Andrew
Publicado: (2011)

Literature and License
Publicado: (1921)

Fraudulent Licenses
por: Nolan, C. T.
Publicado: (1916)

Liquor License
Publicado: (1858)

Liquor License
Publicado: (1876)

Teaching and Licensing
Publicado: (1880)

Efficacy and safety of apatinib in patients with previously treated metastatic colorectal cancer: a real-world retrospective study
por: Gou, Miaomiao, et al.
Publicado: (2018)

The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study
por: Hu, Xingsheng, et al.
Publicado: (2015)

A License to Practice Medicine Cannot Be a License to Harm
por: Schluger, Neil W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4eftql35eqrshcfgdo607q7nqf